These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34408640)

  • 1. Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β Load.
    Schwarz C; Lange C; Benson GS; Horn N; Wurdack K; Lukas M; Buchert R; Wirth M; Flöel A
    Front Aging Neurosci; 2021; 13():675583. PubMed ID: 34408640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe Project.
    Verfaillie SCJ; Timmers T; Slot RER; van der Weijden CWJ; Wesselman LMP; Prins ND; Sikkes SAM; Yaqub M; Dols A; Lammertsma AA; Scheltens P; Ossenkoppele R; van Berckel BNM; van der Flier WM
    Front Aging Neurosci; 2019; 11():7. PubMed ID: 30760996
    [No Abstract]   [Full Text] [Related]  

  • 3. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective cognitive decline-related worries modulate the relationship between global amyloid load and gray matter volume in preclinical Alzheimer's disease.
    Wang X; Wang M; Wang X; Zhou F; Jiang J; Liu H; Han Y
    Brain Imaging Behav; 2022 Jun; 16(3):1088-1097. PubMed ID: 34743296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of amyloid load using
    Bullich S; Roé-Vellvé N; Marquié M; Landau SM; Barthel H; Villemagne VL; Sanabria Á; Tartari JP; Sotolongo-Grau O; Doré V; Koglin N; Müller A; Perrotin A; Jovalekic A; De Santi S; Tárraga L; Stephens AW; Rowe CC; Sabri O; Seibyl JP; Boada M
    Alzheimers Res Ther; 2021 Mar; 13(1):67. PubMed ID: 33773598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status.
    Li S; Daamen M; Scheef L; Gaertner FC; Buchert R; Buchmann M; Buerger K; Catak C; Dobisch L; Drzezga A; Ertl-Wagner B; Essler M; Fliessbach K; Haynes JD; Incesoy EI; Kilimann I; Krause BJ; Lange C; Laske C; Priller J; Ramirez A; Reimold M; Rominger A; Roy N; Scheffler K; Maurer A; Schneider A; Spottke A; Spruth EJ; Teipel SJ; Tscheuschler M; Wagner M; Wolfsgruber S; Düzel E; Jessen F; Peters O; Boecker H;
    J Alzheimers Dis; 2021; 79(2):493-509. PubMed ID: 33337359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between the Subjective Cognitive Decline-Questionnaire's Scores, Gray Matter Volume, and Amyloid-β Levels.
    Valech N; Sánchez-Benavides G; Tort-Merino A; Coll-Padrós N; Olives J; León M; Falcon C; Molinuevo JL; Rami L
    J Alzheimers Dis; 2019; 72(4):1287-1302. PubMed ID: 31707366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported confusion is related to global and regional β-amyloid: data from the Women's healthy ageing project.
    McCluskey GE; Yates P; Villemagne VL; Rowe C; Szoeke CEI
    Brain Imaging Behav; 2018 Feb; 12(1):78-86. PubMed ID: 28108945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in Amyloid Load Between Single Memory Domain and Multidomain Subjective Cognitive Decline: A Study from the SILCODE.
    Wang X; Bi Q; Lu J; Chan P; Hu X; Su L; Jessen F; Lin H; Han C; Shu N; Liu H; Han Y
    J Alzheimers Dis; 2022; 85(4):1573-1582. PubMed ID: 34958039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition.
    Flores-Aguilar L; Iulita MF; Orciani C; Tanna N; Yang J; Bennett DA; Cuello AC
    J Neuroinflammation; 2021 Jul; 18(1):147. PubMed ID: 34218796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging.
    Rauchmann BS; Ghaseminejad F; Mekala S; Perneczky R;
    Radiology; 2020 Jul; 296(1):134-142. PubMed ID: 32368960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences.
    de Wilde A; Reimand J; Teunissen CE; Zwan M; Windhorst AD; Boellaard R; van der Flier WM; Scheltens P; van Berckel BNM; Bouwman F; Ossenkoppele R
    Alzheimers Res Ther; 2019 Sep; 11(1):78. PubMed ID: 31511058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we predict amyloid deposition by objective cognition and regional cerebral blood flow in patients with subjective cognitive decline?
    Funaki K; Nakajima S; Noda Y; Wake T; Ito D; Yamagata B; Yoshizaki T; Kameyama M; Nakahara T; Murakami K; Jinzaki M; Mimura M; Tabuchi H
    Psychogeriatrics; 2019 Jul; 19(4):325-332. PubMed ID: 30688000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.
    Almdahl IS; Lauridsen C; Selnes P; Kalheim LF; Coello C; Gajdzik B; Møller I; Wettergreen M; Grambaite R; Bjørnerud A; Bråthen G; Sando SB; White LR; Fladby T
    Front Aging Neurosci; 2017; 9():9. PubMed ID: 28223932
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.
    Bensamoun D; Guignard R; Furst AJ; Derreumaux A; Manera V; Darcourt J; Benoit M; Robert PH; David R
    J Alzheimers Dis; 2016; 49(2):387-98. PubMed ID: 26484900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
    Miebach L; Wolfsgruber S; Polcher A; Peters O; Menne F; Luther K; Incesoy E; Priller J; Spruth E; Altenstein S; Buerger K; Catak C; Janowitz D; Perneczky R; Utecht J; Laske C; Buchmann M; Schneider A; Fliessbach K; Kalbhen P; Heneka MT; Brosseron F; Spottke A; Roy N; Teipel SJ; Kilimann I; Wiltfang J; Bartels C; Düzel E; Dobisch L; Metzger C; Meiberth D; Ramirez A; Jessen F; Wagner M
    Alzheimers Res Ther; 2019 Jul; 11(1):66. PubMed ID: 31366409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta.
    Li Q; Pan FF; Huang Q; Lo CZ; Xie F; Guo Q
    Front Aging Neurosci; 2022; 14():1046445. PubMed ID: 36389070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.